Selected Publications
Qi L, Cazares L, Johnson C, de Alarcon P, Kupfer G, Semmes OJ. Serum Protein Expression Profiling In Pediatric Hogkin Lymphoma: A Report from the Children’s Oncology Group. Pediatric Blood and Cancer 2008 (in press).
Tebbi CK, London WB, Friedman D, Villaluna D, de Alarcon P, Constine LS, Mendenhall, Sposto R, Chauvenet A, Schwartz C. Dexrazoxane-associated Risk for Secondary Malignancy in Pediatric Hodgkin Disease. Children’s Oncology Group. Journal of Clinical Oncology Feb 10; 25(5):493-500, 2007.
Kung FH, Schwartz CL, Ferree CR, London WB, Ternberg JL, Behm FG, Wharam MD, Falletta JM, de Alarcon P, Chauvenet AR. A Randomized Trial Comparing Chemotherapy with Chemoradiotherapy for Children and Adolescents with Stages I, IIA, IIIA1 Hodgkin Disease. Children’s Oncology Group. J Pediatric Hematol Oncol 28(6):362-8, 2006.
Wimmer RS, Chauvenet AR, London WB, Villaluna D, de Alarcon PA, Schwartz CL. Treatment of Children with Relapsed Hodgkin Disease with APE (cytosine arabinoside (A), cis-platinum (P), and etoposide (E)) chemotherapy: A Pediatric Oncology Group Trial. Pediatr Blood Cancer 46:370-4, 2006.
Tebbi CK, Mendenhall N, London WB, Williams JL, de Alarcon PA, Chauvenet AR. Treatment of Stage I, IIA, IIIA1 Pediatric Hodgkin Disease with Doxorubicin, Bleomycin, Vincristine and Etoposide (DBVE) and Radiation: A Children’s Oncology Group Study. Pediatr Blood Cancer Feb;46(2):198-202, 2006.
Matthay KK, Blaes F, Hero B, Plantaz D, de Alarcon P, Mitchell WG, Pike M, Pistoia V. Opsoclonus Myoclonus Syndrome in Neuroblastoma a Report from a Workshop on the Dancing Eyes Syndrome at the Advances in Neuroblastoma Meeting in Genoa, Italy, 2004. Cancer Lett Oct 18;228(1-2):275-82, 2005.
de Alarcon P, Benjamin R, Dugdale M, Kessler C, Shopnick R, Smith P, Abshire T, Hambleton J, Matthew P, Ortiz I, Cohen A, Konkle BA, Streiff M, Lee M, Wages D, Corash L. Fresh Frozen Plasma Prepared with Amotosalen HCI (S-59) Photochemical Pathogen Inactivation: transfusion of patients with congenital coagulation factor deficiencies. Transfusion Aug;45(8):1362-72, 2005.
de Alarcón PA, Sennett MM. Successful use of Refacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery. Hemophilia 10(5):655-60, 2004.
de Alarcon P. Immune or idiopathic thrombocytopenia purpura (ITP) in childhood: What are the risks and who should be treated? J Pediatr 143(3), 2003:2870289
Johnson MC, Parkerson N, Ward S, de Alarcon PA. Pediatric sinovenous thrombosis. J Pediatr Hematol Oncol 25(4):312-315, 2003.
de Alarcon P. The National Pediatric Blood Club Manuscripts 2001. J Pediatr Hematol Oncol24(9):782-783, 2002.
White J, de Alarcon P. Platelet spherocytosis: A new bleeding disorder. Am J Hematol 70:158-166, 2002.
Lipton JM, de Alarcon PA, Louis K. Diamond: an incomparable legacy. J Pediatr Hematol Oncol23(6):371-2, 2001.
deAlarcon PA. The National Pediatric Blood Club. J Pediatr Hematol Oncol 23(3) 174:2001; with related edited manuscripts 23(3):175-178, 2001.
Amar AM, Tomlinson G, Green DM, Breslow NE, de Alarcon PA. The clinical presentation of rhabdoid tumors. J Pediatr Hematol Oncol 23(2):105-108, 2001.
de Alarcon PA. The National Pediatric Blood Club (Proceedings). J Pediatr Hematol Oncol22(3):265;2000 with related edited manuscripts 22(3):266-293, 2000.
Goldman FD, Rumelhart SL, de Alarcon P, Holida MD, Lee NF, Miller J, Giller R. Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors. Bone Marrow Transplant 25(9):943-948, 2000.
Last update: August 2008